stars 1 stars 2 stars 3

Factor Therapeutics is an Australian biotechnology company pursuing the development and commercialisation of advanced wound care therapeutics. The Company’s lead programme, VF001, is a targeted growth factor that is being developed to treat venous leg ulcers (VLUs). Chronic wounds, such as VLUs, are common, painful and debilitating – a silent epidemic. Factor Therapeutics is a public company traded on the Australian Securities Exchange (ASX:FTT).

Factor Therapeutics Ltd Questions

The Factor Therapeutics Ltd annual revenue was $5.1 million in 2026.

Factor Therapeutics Ltd is based in Darra, Queensland.

The NAICS codes for Factor Therapeutics Ltd are [32, 32541, 325, 3254].

The SIC codes for Factor Therapeutics Ltd are [28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users